학술논문
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
Document Type
Article
Author
Source
In: Clinical Breast Cancer . (Clinical Breast Cancer, April 2019, 19(2):e283-e296)
Subject
Language
English
ISSN
19380666
15268209
15268209